Immunotoxic1ty of bis(tri‐n‐butyltin) oxide in the rat

Authors:

Abstract
Previous studies in the rat have shown that bis(tri‐n‐butyltin) oxide (TBTO), used as a biocide, was immunotoxic at dose levels that did not affect other organs. In order to determine a no‐effect level, weanling rats were treated for at least 28 consecutive days with TBTO at 0, 0.5, 2, 5, or 50 mg/kg of diet. Studies on clinical chemistry, hematology, pathology, and immune function, that is, plaque‐forming cell (PFC) assay, delayed‐type hypersensitivity (DTH) response, and the splenic clearance of Listeria monocytogenes, were performed at the end of treatment. No treatment‐related effects were noted on clinical chemistry and hematology parameters and on PFC and DTH response, whereas thymic atrophy and impaired clearance of L. monocytogenes were noted only at a dietary concentration of 50 mglkg. These results confirm the thymus as a target organ of TBTO immunotoxicity. Under the conditions of these experiments the dietary concentration of 5 mglkg, equivalent to a dose of 0.5 mglkg body weight, represents a no observed effect level (NOEL) for immunotoxicity in the Sprague‐Dawley rat.

This publication has 14 references indexed in Scilit: